The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIxico Regulatory News (IXI)

Share Price Information for Ixico (IXI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.625
Bid: 7.50
Ask: 7.75
Change: 0.00 (0.00%)
Spread: 0.25 (3.333%)
Open: 7.625
High: 7.625
Low: 7.625
Prev. Close: 7.625
IXI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MyBrainBook wins Regional Business Award

21 Jan 2016 07:00

RNS Number : 5173M
IXICO plc
21 January 2016
 

IXICO's MyBrainBook wins Regional Business Award for Partnership with the NHS

 

 

21 January 2016, IXICO plc (Ticker: IXI) ('IXICO' or the 'Company'), the brain health company, is pleased to announce that MyBrainBook®, its digital support platform for people with dementia and their carers, has won the Partnership with the NHS category in the SEHTA Regional Healthcare Business Awards. The award was announced at the Kent Surrey Sussex Academic Health Science Network Expo and Awards 2016.

 

MyBrainBook® has been developed in collaboration with the Health Innovation Network (Academic Health Science Network for South London), Mental Health Trusts, community care providers and 3rd sector partners across South London. It has been designed with input from patients, their carers and professionals to promote self-care and prevent escalating need for people living with dementia. It is currently being evaluated by NHS patients with the support of trained facilitators. Further information including a video introducing MyBrainBook® is available at www.mybrainbook.com

 

Professor Derek Hill, Chief Executive of IXICO, commented:

 

"We are delighted to have received this award for our work in partnership with the NHS as IXICO is committed to improving the lives of people with dementia and their families. MyBrainBook® is a key part of IXICO's evolving digital healthcare platform to support healthcare professionals, patients, carers and organizations developing new treatments. From the outset, we have been working with potential users to develop MyBrainBook® to ensure that it is both relevant and user-friendly."

 

 

Enquiries:

 

IXICO plc

+44 20 3763 7499

Derek Hill, CEO

Susan Lowther, CFO

Charles Spicer, VP Corporate Development

Peel Hunt LLP (Nominated Adviser and Broker)

+44 20 7418 8900

James Steel / Oliver Jackson

Daniel Stewart & Company (Joint Broker)

+44 207 776 6550

Martin Lampshire / David Coffman

FTI Consulting Limited (Investor Relations)

+44 20 3727 1000

Simon Conway / Mo Noonan / Matthew Moss

 

 

Notes to Editors

 

About IXICO

IXICO's innovative and proprietary digital healthcare technologies help those involved in researching and treating serious diseases to capture and analyse clinical data to make rapid, informed decisions. In clinical research this includes the phenotyping of patients, quantification of disease pathology and measurement of patient outcomes. In clinical practice the mobile health and digital decision support technologies aid diagnosis, patient engagement and monitoring. IXICO is also collaborating with partners to develop companion digital health products targeted at improving patient outcomes.

 

The Company's brain health focus includes Alzheimer's disease, Huntington's disease, Multiple Sclerosis, behavioural health, child and adolescent mental health.

 

More information is available on www.ixico.com

 

About MyBrainBook®

MyBrainBook® has been developed by IXICO as a new way of providing the best care to people with dementia. MyBrainBook is a digital hub which gives people with dementia and their carers the ability to build a personal profile and action plan with information they provide about the important aspects of their life. Restricted access is available to health and social care workers to ensure the appropriate support can be provided when needed.

 

More information is available on www.mybrainbook.com

 

About SEHTA

South East Health Technologies Alliance (SEHTA) is one of the largest healthcare technology networking organisations in the UK with 1,300 members from 20 different countries and a database of more than 7,000 contacts spanning academia, industry, clinicians, the NHS and wider health and social care providers, local government, policy-makers, research councils and funding bodies.

 

More information is available on www.sehta.co.uk

 

About the Health Innovation Network

The Health Innovation Network is the Academic Health Science Network (AHSN) for South London, one of 15 AHSNs across England. We connect academics, NHS commissioners and providers, local authorities, patients and patient groups, and industry in order to accelerate the spread and adoption of innovations and best practice, using evidence-based research across large populations. Working as catalysts of change across health and social care economies, we enable health improvements and economic growth.

 

More information is available on www.hin-southlondon.org

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAEAAFEAAFKEAF
Date   Source Headline
7th May 20247:00 amRNSNotice of half year results
15th Apr 20247:00 amRNSLife Molecular Imaging – Neuraceq Supply Agreement
3rd Apr 20247:00 amRNSImeka Collaboration Agreement
13th Mar 20247:00 amRNSTrading Update
29th Jan 202412:00 pmRNSHolding(s) in Company
25th Jan 20244:00 pmRNSResult of AGM
12th Jan 20249:35 amRNSDirectorate Change
27th Dec 20237:00 amRNSUpdate regarding Nominated Adviser and Broker
15th Dec 20237:00 amRNSChange of Auditor
5th Dec 20237:00 amRNSFinancial Results for year ended 30 September 2023
27th Nov 20237:00 amRNSNotice of Results and Investor Presentation
5th Oct 20237:00 amRNSAppointment of Independent Non-Executive Director
29th Sep 20237:00 amRNSTrading Update
18th Jul 20237:00 amRNSContract Win
14th Jun 20237:00 amRNSContract Win
23rd May 20237:00 amRNSHalf year report
16th May 20237:00 amRNSInvestor Meet Company presentation
10th May 20237:00 amRNSTrading Update
3rd Apr 20238:35 amRNSExtension of Huntington's disease consortium
21st Mar 202312:11 pmRNSHolding(s) in Company
10th Mar 20237:00 amRNSContract Win
7th Feb 20237:00 amRNSTrading Update
31st Jan 20234:35 pmRNSPrice Monitoring Extension
31st Jan 20232:05 pmRNSSecond Price Monitoring Extn
31st Jan 20232:00 pmRNSPrice Monitoring Extension
31st Jan 202311:05 amRNSSecond Price Monitoring Extn
31st Jan 202311:00 amRNSPrice Monitoring Extension
27th Jan 20231:00 pmRNSResult of AGM
3rd Jan 20237:00 amRNSTotal Voting Rights
22nd Dec 202212:18 pmRNSDirector Bed & ISA Dealing
13th Dec 20227:00 amRNSPDMR Exercise of Options
9th Dec 20229:05 amRNSContract Win
8th Dec 20223:34 pmRNSContract Update
7th Dec 20227:00 amRNSFinancial Results for the year ended 30 Sept 2022
21st Nov 20227:00 amRNSNotice of Results and Investor Presentation
25th Oct 20227:00 amRNSTrading Update
21st Sep 202210:35 amRNSHD-IH Consortium
14th Sep 20227:00 amRNSGrant of Share Options
1st Sep 20227:00 amRNSTrading Update and FY2023 Guidance
4th Aug 20227:00 amRNSContract Win
26th Jul 202211:22 amRNSContract Win - Replacement
21st Jul 20227:00 amRNSContract Win
14th Jun 20227:00 amRNSContract Extension
24th May 20227:00 amRNSHalf-year Report and Trading Update
16th May 20227:00 amRNSInvestor Presentation
10th May 20227:00 amRNSConsortium Agreement in Huntington's Disease
25th Apr 20227:00 amRNSTrading Update
21st Apr 20227:00 amRNSNew Contract Win
8th Mar 20227:00 amRNSContract worth circa £800k
14th Feb 20227:00 amRNSLaunch of IXIQ.Ai Deep learning AI-based platform

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.